Malondialdehyde: A novel predictive biomarker for post-stroke depression

Journal of Affective Disorders

Volumn 220, Issue , 2017, Pages 95-101

  Liu, Zhihua ^a   Zhu, Zhuoying ^a   Zhao, Jiyun ^a   Ren, Wenwei ^a   Cai, Yan ^a   Wang, Qiongzhang ^a   Luan, Xiaoqian ^a   Zhao, Kai ^a   He, Jincai ^a  

^a THE FIRST AFFILIATED HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Depression; Malondialdehyde; Oxidative stress; Stroke

Indexed keywords

BIOLOGICAL MARKER; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; SUPEROXIDE DISMUTASE;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIETARY INTAKE; DISEASE ASSOCIATION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HAMILTON DEPRESSION RATING SCALE; HOSPITAL ADMISSION; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; OXIDATIVE STRESS; POST-STROKE DEPRESSION; PRIORITY JOURNAL; STROKE PATIENT; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS; BLOOD; CEREBROVASCULAR ACCIDENT; DEPRESSION; MIDDLE AGED; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

AGED; BIOMARKERS; DEPRESSION; DEPRESSIVE DISORDER; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUTATHIONE PEROXIDASE; HUMANS; MALE; MALONDIALDEHYDE; MIDDLE AGED; OXIDATIVE STRESS; ROC CURVE; SENSITIVITY AND SPECIFICITY; STROKE; SUPEROXIDE DISMUTASE;

EID: 85020277194     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2017.05.023     Document Type: Article

References (56)

1. Adams, H.P. Jr., Bendixen, B.H., Kappelle, L.J., Biller, J., Love, B.B., Gordon, D.L., Marsh, E.E. 3rd, Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. trial of Org 10172 in acute stroke Treatment. Stroke 24:1 (1993), 35–41.
2. Ayala, A., Muñoz, M.F., Argüelles, S., Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxid. Medicine Cell. Longev. 2014 (2014), 1–31.
3. Ayerbe, L., Ayis, S., Wolfe, C.D.A., Rudd, A.G., Natural history, predictors and outcomes of depression after stroke: systematic review and meta-analysis. Br. J. Psychiatry 202:1 (2013), 14–21.
4. Bilici, M., Efe, H., Koroglu, M.A., Uydu, H.A., Bekaroglu, M., Deger, O., Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments. J. Affect. Disord. 64:1 (2001), 43–51.
5. Brott, T., Adams, H.P. Jr., Olinger, C.P., Marler, J.R., Barsan, W.G., Biller, J., Spilker, J., Holleran, R., Eberle, R., Hertzberg, V., et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke 20:7 (1989), 864–870.
6. Buysse, D.J., Reynolds, C.F. 3rd, Monk, T.H., Berman, S.R., Kupfer, D.J., The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 28:2 (1989), 193–213.
7. Camkurt, M.A., Findikli, E., Izci, F., Kurutas, E.B., Tuman, T.C., Evaluation of malondialdehyde, superoxide dismutase and catalase activity and their diagnostic value in drug naive, first episode, non-smoker major depression patients and healthy controls. Psychiatry Res. 238 (2016), 81–85.
8. Chan, P.H., Kawase, M., Murakami, K., Chen, S.F., Li, Y., Calagui, B., Reola, L., Carlson, E., Epstein, C.J., Overexpression of SOD1 in transgenic rats protects vulnerable neurons against ischemic damage after global cerebral ischemia and reperfusion. J. Neurosci. Off. J. Soc. Neurosci. 18:20 (1998), 8292–8299.
9. Cichon, N., Bijak, M., Miller, E., Niwald, M., Saluk, J., Poststroke depression as a factor adversely affecting the level of oxidative damage to plasma proteins during a brain stroke. Oxid. Med. Cell Longev., 2015, 2015, 408745.
10. Cojocaru, I.M., Cojocaru, M., Sapira, V., Ionescu, A., Evaluation of oxidative stress in patients with acute ischemic stroke. Rom. J. Intern. medicine =Rev. Roum. De. Méd. Internet, 51(2), 2013, 97.
11. Crack, P.J., Taylor, J.M., Flentjar, N.J., De, H.J., Hertzog, P., Iannello, R.C., Kola, I., Increased infarct size and exacerbated apoptosis in the glutathione peroxidase-1 (Gpx-1) knockout mouse brain in response to ischemia/reperfusion injury. J. Neurochem. 78:6 (2001), 1389–1399.
12. Cumming, T.B., Churilov, L., Skoog, I., Blomstrand, C., Linden, T., Little evidence for different phenomenology in poststroke depression. Acta Psychiatr. Scand., 121(6), 2010, 424.
13. De Ryck, A., Brouns, R., Geurden, M., et al. Risk factors for poststroke depression: identification of inconsistencies based on a systematic review. J. Geriatr. Psychiatry Neurol. 27 (2014), 147–158.
14. Ellis, C., Zhao, Y.M., Egede, L.E., Depression and increased risk of death in adults with stroke. J. Psychosom. Res. 68:6 (2010), 545–551.
15. Feng, Z., Hu, W., Marnett, L.J., Tang, M.S., Malondialdehyde, a major endogenous lipid peroxidation product, sensitizes human cells to UV- and BPDE-induced killing and mutagenesis through inhibition of nucleotide excision repair. Mutat. Res 601:1–2 (2006), 125–136.
16. Folstein, M.F., Robins, L.N., Helzer, J.E., The mini-mental state examination. Arch. Gen. Psychiatry, 40(7), 1983, 812.
17. Galecki, P., Kedziora, J., Florkowski, A., Galecka, E., [Lipid peroxidation and copper-zinc superoxide dismutase activity in patients treated with fluoxetine during the first episode of depression]. Psychiatr. Pol. 41:5 (2007), 615–624.
18. Hackett, M.L., Pickles, K., Part I: frequency of depression after stroke: an updated systematic review and meta-analysis of observational studies. Int J. Stroke 9:8 (2014), 1017–1025.
19. Hackett, M.L., Köhler, S., O'Brien, J.T., Mead, G.E., Neuropsychiatric outcomes of stroke. Lancet Neurol. 13:5 (2014), 525–534.
20. Halliwell, B., Antioxidants in human health and disease. Annu Rev. Nutr. 16 (1996), 33–50.
21. Hsieh, Y.W., Lin, K.C., Korivi, M., Lee, T.H., Wu, C.Y., Wu, K.Y., The Reliability and Predictive ability of a biomarker of oxidative DNA damage on functional outcomes after stroke rehabilitation. Int. J. Mol. Sci. 15:4 (2014), 6504–6516.
22. Kotan, V.O., Sarandol, E., Kirhan, E., Ozkaya, G., Kirli, S., Effects of long-term antidepressant treatment on oxidative status in major depressive disorder: a 24-week follow-up study. Prog. Neuropsychopharmacol. Biol. Psychiatry 35:5 (2011), 1284–1290.
23. Leonard, B., Maes, M., Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression. Neurosci. Biobehav Rev. 36:2 (2012), 764–785.
24. Li, H., Horke, S., Forstermann, U., Oxidative stress in vascular disease and its pharmacological prevention. Trends Pharmacol. Sci. 34:6 (2013), 313–319.
25. Lobbestael, J., Leurgans, M., Arntz, A., Inter-rater reliability of the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID I) and Axis II Disorders (SCID II). Clin. Psychol. Psychother. 18:1 (2011), 75–79.
26. Long, J., Wang, X., Gao, H., Liu, Z., Liu, C., Miao, M., Liu, J., Malonaldehyde acts as a mitochondrial toxin: inhibitory effects on respiratory function and enzyme activities in isolated rat liver mitochondria. Life Sci. 79:15 (2006), 1466–1472.
27. Lopresti, A.L., Maker, G.L., Hood, S.D., Drummond, P.D., A review of peripheral biomarkers in major depression: the potential of inflammatory and oxidative stress biomarkers. Prog. Neuropsychopharmacol. Biol. Psychiatry 48 (2014), 102–111.
28. Lorente, L., Martin, M.M., Perez-Cejas, A., Abreu-Gonzalez, P., Ramos, L., Argueso, M., Caceres, J.J., Sole-Violan, J., Jimenez, A., Association between total antioxidant capacity and mortality in ischemic stroke patients. Ann. Intensive Care, 6(1), 2016, 39.
29. Lushchak, V.I., Free radicals, reactive oxygen species, oxidative stress and its classification. Chem.-Biol. Interact. 224 (2014), 164–175.
30. Maaijwee, N.A.M.M., Tendolkar, I., Rutten-Jacobs, L.C.A., Arntz, R.M., Schaapsmeerders, P., Dorresteijn, L.D., Schoonderwaldt, H.C., van Dijk, E.J., de Leeuw, F.E., Long-term depressive symptoms and anxiety after transient ischaemic attack or ischaemic stroke in young adults. Eur. J. Neurol. 23:8 (2016), 1262–1268.
31. Maes, M., Galecki, P., Chang, Y.S., Berk, M., A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness. Prog. Neuropsychopharmacol. Biol. Psychiatry 35:3 (2011), 676–692.
32. Maes, M., Bosmans, E., Ranjan, R., Vandoolaeghe, E., Meltzer, H.Y., De Ley, M., Berghmans, R., Stans, G., Desnyder, R., Lower plasma CC16, a natural anti-inflammatory protein, and increased plasma interleukin-1 receptor antagonist in schizophrenia: effects of antipsychotic drugs. Schizophr. Res 21:1 (1996), 39–50.
33. Mahoney, F.I., Barthel, D.W., Functional evaluation: the Barthel index. Md State Med J. 14 (1965), 61–65.
34. Mast, B.T., Cerebrovascular disease and late-life depression: a latent-variable analysis of depressive symptoms after stroke. Am. J. Geriatr. Psychiatry 12:3 (2004), 315–322.
35. Michalakeas, C.A., Parissis, J.T., Douzenis, A., Nikolaou, M., Varounis, C., Andreadou, I., Antonellos, N., Markantonis-Kiroudis, S., Paraskevaidis, I., Ikonomidis, I., Lykouras, E., Kremastinos, D., Effects of sertraline on circulating markers of oxidative stress in depressed patients with chronic heart failure: a pilot study. J. Card. Fail 17:9 (2011), 748–754.
36. Milanlioglu, A., Aslan, M., Ozkol, H., Cilingir, V., Nuri Aydin, M., Karadas, S., Serum antioxidant enzymes activities and oxidative stress levels in patients with acute ischemic stroke: influence on neurological status and outcome. Wien. Klin. Wochenschr. 128:5–6 (2016), 169–174.
37. Moylan, S., Maes, M., Wray, N.R., Berk, M., The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications. Mol. Psychiatry 18:5 (2013), 595–606.
38. Muller, M.J., Dragicevic, A., Standardized rater training for the Hamilton Depression Rating Scale (HAMD-17) in psychiatric novices. J. Affect Disord. 77:1 (2003), 65–69.
39. Niizuma, K., Endo, H., Chan, P.H., Oxidative stress and mitochondrial dysfunction as determinants of ischemic neuronal death and survival. J. Neurochem 109:Suppl 1 (2009), 133–138.
40. Odebrecht Vargas, H., Vargas Nunes, S.O., Pizzo de Castro, M., Cristina Bortolasci, C., Sabbatini Barbosa, D., Kaminami Morimoto, H., Venugopal, K., Dodd, S., Maes, M., Berk, M., Oxidative stress and lowered total antioxidant status are associated with a history of suicide attempts. J. Affect. Disord. 150:3 (2013), 923–930.
41. Poynter, B., Shuman, M., Diaz-Granados, N., Kapral, M., Grace, S.L., Stewart, D.E., Sex differences in the prevalence of post-stroke depression: a systematic review. Psychosomatics 50:6 (2009), 563–569.
42. Rajashekaran, P., Pai, K., Thunga, R., et al. Post-stroke depression and lesion location: a hospital based cross-sectional study. Indian J. Psychiatry 55 (2013), 343–348.
43. Robinson, R.G., Spalletta, G., Poststroke depression: a review. Can. J. Psychiatry 55:6 (2010), 341–349.
44. Robinson, R.G., Jorge, R.E., Post-Stroke Depression: a Review. Am. J. Psychiatry 173:3 (2016), 221–231.
45. Rybka, J., Kedziora-Kornatowska, K., Banas-Lezanska, P., Majsterek, I., Carvalho, L.A., Cattaneo, A., Anacker, C., Kedziora, J., Interplay between the pro-oxidant and antioxidant systems and proinflammatory cytokine levels, in relation to iron metabolism and the erythron in depression. Free Radic. Biol. Med 63 (2013), 187–194.
46. Sasaki, T., Shimizu, T., Koyama, T., Sakai, M., Uchiyama, S., Kawakami, S., Noda, Y., Shirasawa, T., Kojima, S., Superoxide dismutase deficiency enhances superoxide levels in brain tissues during oxygenation and hypoxia-reoxygenation. J. Neurosci. Res. 89:4 (2011), 601–610.
47. Sharpe, P.C., Mulholland, C., Trinick, T., Ascorbate and malondialdehyde in stroke patients. Ir. J. Medical Sci. 163:11 (1994), 488–491.
48. Shichiri, M., The role of lipid peroxidation in neurological disorders. J. Clin. Biochem Nutr. 54:3 (2014), 151–160.
49. Sies, H., Stahl, W., Vitamins E and C, beta-carotene, and other carotenoids as antioxidants. Am. J. Clin. Nutr. 62:6 Suppl (1995), 1315s–1321s.
50. Stefanescu, C., Ciobica, A., The relevance of oxidative stress status in first episode and recurrent depression. J. Affect Disord. 143:1–3 (2012), 34–38.
51. Tang, W.K., Liang, H., Chu, W.C., Mok, V., Ungvari, G.S., Wong, K.S., Association between high serum total bilirubin and post-stroke depression. Psychiatry Clin. Neurosci. 67:4 (2013), 259–264.
52. Tsai, M.C., Huang, T.L., Increased activities of both superoxide dismutase and catalase were indicators of acute depressive episodes in patients with major depressive disorder. Psychiatry Res 235 (2016), 38–42.
53. Wang, L., Tao, Y., Chen, Y., Wang, H., Zhou, H., Fu, X., Association of post stroke depression with social factors, insomnia, and neurological status in Chinese elderly population. Neurol. Sci. 37:8 (2016), 1305–1310.
54. Wei, Y.C., Zhou, F.L., He, D.L., Bai, J.R., Ding, H., Wang, X.Y., Nan, K.J., Oxidative stress in depressive patients with gastric adenocarcinoma. Int J. Neuropsychopharmacol. 12:8 (2009), 1089–1096.
55. Youden, W.J., Index for rating diagnosis tests. Cancer 3:1 (1950), 32–35.
56. Zimmerman, M., Martinez, J.H., Young, D., Chelminski, I., Dalrymple, K., Severity classification on the Hamilton Depression Rating Scale. J. Affect. Disord. 150:2 (2013), 384–388.